Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS42001644EBVENSG00000107643.17protein_codingMAPK8NoNo5599A1L4K2
P45983
TVIS10042928HBVENSG00000107643.17protein_codingMAPK8NoNo5599A1L4K2
P45983
TVIS30005591HIVENSG00000107643.17protein_codingMAPK8NoNo5599A1L4K2
P45983
TVIS30014683HIVENSG00000107643.17protein_codingMAPK8NoNo5599A1L4K2
P45983
TVIS30027616HIVENSG00000107643.17protein_codingMAPK8NoNo5599A1L4K2
P45983
TVIS30027617HIVENSG00000107643.17protein_codingMAPK8NoNo5599A1L4K2
P45983
TVIS30027618HIVENSG00000107643.17protein_codingMAPK8NoNo5599A1L4K2
P45983
TVIS30027619HIVENSG00000107643.17protein_codingMAPK8NoNo5599A1L4K2
P45983
TVIS30021132HIVENSG00000107643.17protein_codingMAPK8NoNo5599A1L4K2
P45983
TVIS30027620HIVENSG00000107643.17protein_codingMAPK8NoNo5599A1L4K2
P45983
TCGA Plot Options
Drug Information
GeneMAPK8
DrugBank IDDB00675
Drug NameTamoxifen
Target IDBE0003790
UniProt IDP45983
Regulation Typemodulator
PubMed IDs27083550
CitationsRadin DP, Patel P: Delineating the molecular mechanisms of tamoxifen's oncolytic actions in estrogen receptor-negative cancers. Eur J Pharmacol. 2016 Jun 15;781:173-80. doi: 10.1016/j.ejphar.2016.04.017. Epub 2016 Apr 12.
GroupsApproved
Direct ClassificationStilbenes
SMILESCCC(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
PathwaysTamoxifen Metabolism Pathway; Tamoxifen Action Pathway
PharmGKBPA451581
ChEMBLCHEMBL83